Abstract Expression of the receptor tyrosine kinase HER3 is negatively correlated with survival in ovarian cancer, and HER3 overexpression is associated with cancer progression and therapeutic resistance. Thus, improvements in HER3-targeted therapy could lead to significant clinical impact for ovarian cancer patients. Previous work from our group established multivalency as a potential strategy to improve the therapeutic efficacy of HER3-targeted ligands, including affibodies....
Anapafseos 5 Agios Nikolaos 72100,Crete,Greece,00302841026182,00306932607174,alsfakia@gmail.com
Blog Archive
- ► 2022 (3010)
- ► 2021 (9899)
- ► 2020 (4138)
-
▼
2019
(2429)
-
▼
April
(373)
-
▼
Apr 04
(26)
- Otolaryngology
- Molecular Pharmaceutics
- Macromolecules
- The American Association of Pharmaceutical Scientists
- Abdominal Radiology
- Biotech
- Biomacromolecules
- Cytology
- Neuro
- Surgical
- Oral Diseases
- Allergy , Immunology
- Cellular Physiology
- Magnesium sulphate optimises surgical field
- Aneurysmal subarachnoid haemorrhage patients : Ful...
- Aprepitant and ondansetron for the prevention of p...
- C-MAC(R) video laryngoscope Miller blade size zero...
- Biweekly cetuximab in combination with platinum an...
- Thyromental height (TMH) has been reported to be u...
- The glymphatic system (or glymphatic clearance pat...
- Otolaryngologic Clinics
- Ear and Hearing
- Investigative Radiology,https://journals.lww.com/i...
- Cancer
- Anaesthesia
- Urology
-
▼
Apr 04
(26)
-
▼
April
(373)
Αλέξανδρος Γ. Σφακιανάκης
Thursday, April 4, 2019
The American Association of Pharmaceutical Scientists
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment